Milbank LLP To Host Call for Unsecured Bondholders of Braskem S.A.

NEW YORK, Sept. 29, 2025 /PRNewswire/ — Milbank LLP has been analyzing recent developments implicating unsecured creditors of Braskem S.A., including the company’s announcement that it has engaged financial and legal advisors to support the company in evaluating economic and financial alternatives to optimize its capital structure. Given its extensive familiarity with Braskem’s bank and bond […]

Education in Motion launches EiM Education Advisory Board

Leading thinkers from academia, policy, and industry to explore bold ideas on the future of learning SINGAPORE, Sept. 29, 2025 /PRNewswire/ — Education in Motion (EiM), a leading global education group, today announced the launch of its EiM Education Advisory Board, a pioneering initiative designed to advance thought leadership and innovation in education worldwide. Formed […]

New Agricultural Practices in Xinjiang: More Smart Technologies, a Happier Life

BEIJING, Sept. 28, 2025 /PRNewswire/ — A news report from China.org.cn on the technological application in Xinjiang’s agriculture: To cultivate a cotton field of 3,000 mu, equivalent to about 280 standard football pitches, how many farmers are needed? Continue Reading New Agricultural Practices in Xinjiang: More Smart Technologies, a Happier Life In Yuli County, Xinjiang, […]

Leqembi® approved for IV maintenance treatment in China

STOCKHOLM, Sept. 29, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab (Leqembi) has been approved for once every four weeks intravenous (IV) maintenance dosing for the treatment of early Alzheimer’s disease by the National Medical Products Administration (NMPA) in China. In January 2024, lecanemab was approved for […]

Leqembi® approved for IV maintenance treatment in China

STOCKHOLM, Sept. 29, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab (Leqembi) has been approved for once every four weeks intravenous (IV) maintenance dosing for the treatment of early Alzheimer’s disease by the National Medical Products Administration (NMPA) in China. In January 2024, lecanemab was approved for […]

BofA Unveils AI-Driven Capital Markets Insights on CashPro® App

C-Suite and Treasury Teams to Have Consolidated Capital Markets Knowledge  In the Palm of Their Hand NEW YORK, Sept. 29, 2025 /PRNewswire/ — This week, Bank of America is unveiling Capital Markets Insights on the CashPro® App, providing a centralized view of market and issuance data relating to the Investment Grade Capital Markets – including […]

Bondaval Partners with Swiss Re Corporate Solutions to Launch Data-Driven Credit Risk Solution

LONDON, Sept. 29, 2025 /PRNewswire/ — Bondaval, a pioneering credit fintech combining advanced technology with deep underwriting expertise, has entered into a global partnership with Swiss Re Corporate Solutions, in a move set to elevate the way businesses approach and protect against credit risk. Continue Reading Thomas Powell, CEO, Bondaval Katie McGrath, Swiss Re Corporate […]